- Home
- HAYW vs HAE Comparison
HAYW vs HAE Comparison
Compare HAYW & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HAYW | HAE |
|---|---|---|
| Founded | 1925 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electronic Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.8B |
| IPO Year | 2021 | 1996 |
Fundamental Metrics
Financial Performance| Metric | HAYW | HAE |
|---|---|---|
| Price | $14.71 | $108.84 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 9 |
| Target Price | $17.50 | ★ $84.13 |
| AVG Volume (30 Days) | ★ 2.6M | 842.0K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.93 | N/A |
| EPS | 0.11 | ★ 0.72 |
| Revenue | ★ $1,122,155,000.00 | $910,373,000.00 |
| Revenue This Year | $6.22 | N/A |
| Revenue Next Year | $5.96 | $5.23 |
| P/E Ratio | ★ $137.27 | $150.57 |
| Revenue Growth | ★ 6.71 | N/A |
| 52 Week Low | $12.93 | $47.32 |
| 52 Week High | $17.73 | $108.50 |
Technical Indicators
Market Signals| Indicator | HAYW | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 43.31 | 84.95 |
| Support Level | $14.12 | $79.52 |
| Resistance Level | $16.37 | N/A |
| Average True Range (ATR) | 0.39 | 3.26 |
| MACD | -0.08 | 2.07 |
| Stochastic Oscillator | 10.50 | 96.71 |
Price Performance
Historical ComparisonAbout HAYW Hayward Holdings Inc.
Hayward Holdings is a leading manufacturer of energy-efficient swimming pool equipment and pool automation systems. The company offers a wide range of pool equipment, including pumps, filters, heaters, LED lights, and sanitization. Headquartered in Charlotte, North Carolina, the company has around 2,000 full-time employees. Hayward generated approximately $1.1 billion in revenue in 2025.
About HAE Haemonetics Corporation
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.